Technology

Palantir Stock: More Insider Selling, Technical Outlook Sags. Is PLTR Stock A Buy Or Sell?

2025-11-24 13:10
532 views
Palantir Stock: More Insider Selling, Technical Outlook Sags. Is PLTR Stock A Buy Or Sell?

Technology Palantir Stock: More Insider Selling, Technical Outlook Sags. Is PLTR Stock A Buy Or Sell? Licensing REINHARDT KRAUSE Updated 08:10 AM ET 11/24/2025 There's plenty for bulls and bears to ha...

  • Technology
Palantir Stock: More Insider Selling, Technical Outlook Sags. Is PLTR Stock A Buy Or Sell? FacebookXLinkedInShare Licensing

There's plenty for bulls and bears to hash out over Palantir Technologies (PLTR), a maker of data analytics software, amid the company's premium valuation. As the trade in artificial stocks loses momentum, some technical ratings for Palantir stock have weakened. PLTR stock has retreated 25% from its record high. It's not alone. Many artificial intelligence stocks have pulled back from…

Related news

Breakthrough and success concept

Dow Jones Futures: Market Reclaims Key Level Despite Nvidia; What To Do Now

8:47 AM ET The major indexes broke above their 50-day moving averages, despite Nvidia and AMD woes. Here's what to do now.

8:47 AM ET The major indexes broke above their 50-day moving averages, despite...

Today's Spotlight

It’s our biggest deal of the year: Join IBD Digital today for only $1/week. Learn how to read key market signals and position your portfolio for the upcoming year. David Ryan’s Ants Indicator spots stocks under heavy accumulation—try it in MarketSurge.

More News

  • Federal Reserve Dow Jones on stock market today Consumer Confidence Dives, Employment Falls, Supporting Fed Cut
  • Tesla model Y, interior steering wheel screen playing games, white seats. 07,17,2023 New York What Musk And Tesla Are Saying About FSD With Weeks To Go Before This Big Deadline
  • biotech stocks

    The antibody drug conjugates market could be worth north of $32 billion by 2033, according to Grand View Research. (© Dave Cutler)

    Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street.

Partner Center